Abstract: Hardeners for epoxy resins produced by reacting one or more &agr;,&bgr;-unsaturated carboxylic acid esters with one or more hydroxy compounds, reacting the thus formed intermediate with one or more aminopolyalkylene oxide compounds, reacting the thus formed intermediate with one or more polyepoxide compounds, and reacting the thus formed intermediate with one or more amines are described. Processes for their production, aqueous dispersions containing the same and methods for their use are also described.

Abstract: A food additive useful for lowering serum cholesterol in humans contains a sterol or stanol ester of a fatty acid or a dicarboxylic acid ester of a sterol or stanol made by reacting a sterol, stanol and a carboxylic acid in the presence of an effective amount of a catalyst selected from the group consisting of calcium oxide, calcium hydroxide, a calcium salt of a carboxylic acid, magnesium hydroxide and combinations thereof described herein below.

Abstract: Hardeners for epoxy resins produced by reacting one or more &agr;,&bgr;-unsaturated carboxylic acid esters with one or more aminopolyalkylene oxide compounds, reacting the thus formed intermediate with one or more polyhydroxy compounds, reacting the thus formed intermediate with one or more polyepoxide compounds, and reacting the thus formed intermediate with one or more amines are described. Processes for their production, aqueous dispersions containing the same and methods for their use are also described.

Abstract: Hardeners for epoxy resins produced by reacting one or more &agr;,&bgr;-unsaturated carboxylic acid esters with one or more aminopolyalkylene oxide compounds, reacting the thus formed intermediate with one or more polyepoxide compounds, and reacting the thus formed intermediate with one or more amines are described. Processes for their production, aqueous dispersions containing the same and methods for their use are also described.

Abstract: A method of preparing a modified cationic layer compound which includes providing a layer compound of the general formula (I): [EeZzDdVv(OH−)x](An−)a.qH2O  (I) wherein E represents one or more monovalent alkali metal cations, e represents a number of from 0 to about 2, Z represents one or more divalent metal cations, z represents a number of from 0 to about 6, D represents one or more trivalent metal cations, d represents a number of from 0 to about 3, V represents one or more tetravalent metal cations, v represents a number of from 0 to about 1, (An−) represents an acid anion wherein n represents an integer of from 1 to 3, q represents a number of from about 1 to about 10, and wherein x>a and e+2z+3d+4v=x+na; subjecting the layer compound to crystallization to provide a resultant material; and subjecting the resultant material to steam drying at a temperature of from about 200° C. to about 260° C.

Abstract: A method for preventing or treating high serum levels of cholesterol and lipids in a mammal, said method comprising orally administering an effective amount of natural lycopene to prevent or treat high serum levels of cholesterol or lipid to a mammal in need of such treatment. Also disclosed is an oral pharmaceutical composition in unit dosage form for oral administration for the prevention or treatment of high serum levels of cholesterol and/or lipids in a mammal, said composition comprising an effective amount of natural lycopene to prevent or treat high serum levels of cholesterol or lipid in a mammal and in a sufficient amount to achieve a level of serum cholesterol of less than 200 mg per deciliter over the course of treatment, and a pharmaceutically acceptable carrier therefor.

Abstract: Pharmaceutical compositions comprising natural tocotrienols and natural tocopherols are disclosed. Also disclosed is a method for preventing or treating the harmful effects of high serum cholesterol and/or lipid levels in a mammal, said method comprising orally administering approximately 100 mg to approximately 1000 mg of natural tocotrienols and approximately 100 mg to approximately 1000 mg of tocopherols to a mammal, including humans, in need of such prevention or treatment.

Abstract: Compositions comprising: (a) from about 51% to about 99.9% by weight of a polyamide resin component; and (b) from about 0. 1% to about 49% by weight of a wax component, wherein the polyamide resin component comprises a reaction product obtained by reaction of a dimerized fatty acid reactant, a carboxylic acid reactant and a diamine reactant, are disclosed for use in thermographic printing. The polyamide resin/wax component compositions disclosed herein exhibit decreased bloom and enhanced scratch/scuff resistance.

Abstract: The invention relates to the use of nanoscale sterols and/or sterol esters with particle diameters of 10 to 300 nm as food additives and as active substances for the production of hypocholesterolemic agents. The particular fineness of the particles promotes more rapid absorption by the blood serum after oral ingestion by comparison with conventional sterols and sterol esters.

Abstract: A cosmetic preparation is presented containing (a) alkyl or alkenyl oligoglycosides (b) polyol poly-12-hydroxystearates and (c) dihydroxyacetone. This self-tanning cosmetic preparation has high dermatological compatibility, a favorable feeling on the skin and good storage stability at relatively high temperatures.

Abstract: A process for producing glucoprotamines by condensation of N-substituted propylene diamines with 2-aminoglutaric compounds in which the reaction is carried out in the presence of aminosilicones is disclosed. Glucoprotamines produced in accordance with the disclosed process exhibit improved color quality and longer storage stability.

Abstract: The present invention provides an antioxidant carotenoid composition substantially free of lutein comprising lutein esters. This antioxidant composition may readily be formulated into products for administration to humans to provide protection from the harmful effects of free radicals. The invention also provides a method of preventing or inhibiting the harmful effects of free radicals by administering an effective amount of an antioxidant carotenoid composition substantially free of lutein comprising lutein esters.

Abstract: Pigment concentrates comprising a pigment, a liquid carrier medium and a dimerdiolalkoxylate, wherein a dimer portion of the dimerdiolalkoxylate comprises from about 36 to about 44 carbon atoms, and wherein the at least one dimerdiolalkoxylate has from about 1 to about 200 moles of alkylene oxide per mole of dimerdiol, are described in conjunction with methods of preparing the same.

Abstract: Pigment concentrates comprising a pigment, a liquid carrier medium and a diol alkoxylate of the general formulae (I), (II) and/or (III) are described in conjunction with methods of preparing the same.

Abstract: Cosmetic formulations, such as for example, skin cleansers, containing from about 20% to about 80% by weight of one or more ethoxylated partial glycerides of the general formula (I) and up to about 80% by weight of an oil component, the balance of the formulations containing water, cosmetic auxiliaries and/or additives, are disclosed. The cosmetic formulations disclosed are transparent, and spread easily and smoothly when applied to skin. Such formulations are especially suitable for removing decorative makeup.

Abstract: A process for refining epoxy compounds, wherein the process comprises: (a) providing a washed and dried organic phase comprising at least one epoxide compound; (b) contacting the organic phase with at least one basic solid selected from the group consisting of aluminum oxides, aluminum hydroxides and alkali metal silicates; and (c) separating the organic phase and the at least one basic solid, is disclosed.

Abstract: A method for preventing or treating high serum levels of cholesterol and lipids in a mammal, said method comprising orally administering an effective amount of natural lycopene to prevent or treat high serum levels of cholesterol or lipids to a mammal in need of such treatment. Also disclosed is an oral pharmaceutical composition in unit dosage form for oral administration for the prevention or treatment of high serum levels of cholesterol and/or lipids in a mammal, said composition comprising an effective amount of natural lycopene to prevent or treat high serum levels of cholesterol or lipids in a mammal and in a sufficient amount to achieve a level of serum cholesterol of less than 200 mg per deciliter over the course of treatment, and a pharmaceutically acceptable carrier therefor.

Abstract: A process useful for protecting metal surfaces against corrosion in is presented involving: (a) forming a corrosion inhibitor having a compound corresponding to formula (I): where R1, R2 and R3 independently of one another represent an alkyl or hydroxyalkyl group containing 1 to 4 carbon atoms, an aryl or alkylaryl group or a group corresponding to formula (II): A− is an anion, n is the number 2 or 3, p is a number of 1 to 3 and R5 is an alkyl or alkenyl group containing 7 to 23 carbon atoms and 0, 1, 2 or 3 double bonds, and R4 is a group corresponding to formula (II) or (III): where R1, R2 and R3 are as defined above and Z is a group —(CH2)m— or a group corresponding to formula (IV):  m is an integer of 1 to 6, X is a group NH or an oxygen atom and D is a dimer fatty acid residue containing on average 36 to 54 carbon atoms; (b) combining the corrosion inhibitor with liquid aqueous, liquid non-aqueous or gaseous me

Abstract: Highly foaming detergent mixtures comprising: (a) at least one fatty acid polyglycol ester sulfate of the general formula (I): R1COO(AO)xSO3X  (I) wherein R1CO represents an acyl group and R1 is selected from the group consisting of linear, branched, saturated and unsaturated chains having from about 6 to about 22 carbon atoms, x is an integer having a value of from 1 to 3, each AO independently represents a CH2CH2O, CH2CH(CH3)O or CH(CH3)CH2O group, and X is selected from the group consisting of an alkali metal, an alkaline earth metal, ammonium, an alkylammonium, an alkanolammonium or a glucammonium; and (b) at least one additional surfactant selected from the group consisting of anionics, nonionics, cationics, amphoterics and zwitterionics are disclosed. The disclosed detergent mixtures exhibit advantageous foaming performance and a high level of foam stability even in the presence of hard water and/or oil.

Abstract: A method of producing fatty acid polyglycol ester sulfates of the general formula (I): R1COO(AO)nSO3M  (I) is disclosed, wherein R1CO represents a linear or branched, aliphatic, saturated and/or unsaturated acyl radical with 6 to 22 carbon atoms, AO represents CH2CH2O, CHCH3CH2O and/or CH2CHCH3, n represents a number from about 0.5 to about 5 and M represents a cation. The disclosed process comprises the sulfation of fatty acid polyglycol esters followed by neutralization, wherein the neutralization is carried out at a pH of from about 5 to about 9.